PATENT CLAIM ANALYSIS

Application Number: 16028160
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "055000"]

Abstract:
The present invention relates generally to therapeutic compositions comprising chitosan-derived compositions used in connection with methods for treating neoplasms, such as for instance, malignant lung, thyroid and kidney neoplasms, and other types of malignant neoplasms, and other medical disorders.

Claim (Index 2):
The method, according to  claim 1 , in which the formulation is administered by injection to the subject.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 95.0
- Lexical Diversity: 1.36364
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13037171', '13755105', '13258722', '10870342', '11818997']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7366308796092553
- 35 USC 102 Novelty (BERT): 0.5064482171636521
- Combined Prediction Score: 0.7136126133646951
- Mean Citation Score: 155.62205
- Max Citation Score: 195.53748
- Similarity Product: 114.790328300364

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test